annual operating expenses:
$1.17B+$36.80M(+3.25%)Summary
- As of today (May 29, 2025), IONS annual total operating expenses is $1.17 billion, with the most recent change of +$36.80 million (+3.25%) on December 31, 2024.
- During the last 3 years, IONS annual operating expenses has risen by +$354.68 million (+43.55%).
- IONS annual operating expenses is now at all-time high.
Performance
IONS Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$277.06M-$56.53M(-16.95%)Summary
- As of today (May 29, 2025), IONS quarterly total operating expenses is $277.06 million, with the most recent change of -$56.53 million (-16.95%) on March 31, 2025.
- Over the past year, IONS quarterly operating expenses has increased by +$10.24 million (+3.84%).
- IONS quarterly operating expenses is now -22.21% below its all-time high of $356.17 million, reached on December 31, 2022.
Performance
IONS quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
IONS Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.3% | +3.8% |
| 3 y3 years | +43.5% | +41.9% |
| 5 y5 years | +55.4% | +44.3% |
IONS Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +43.5% | -22.2% | +41.9% |
| 5 y | 5-year | at high | +55.4% | -22.2% | +50.2% |
| alltime | all time | at high | >+9999.0% | -22.2% | +1934.8% |
IONS Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $277.06M(-16.9%) |
| Dec 2024 | $1.17B(+3.3%) | $333.59M(+18.6%) |
| Sep 2024 | - | $281.36M(-2.0%) |
| Jun 2024 | - | $287.18M(+7.6%) |
| Mar 2024 | - | $266.81M(-18.5%) |
| Dec 2023 | $1.13B(+15.1%) | $327.56M(+14.8%) |
| Sep 2023 | - | $285.33M(+3.4%) |
| Jun 2023 | - | $276.07M(+13.5%) |
| Mar 2023 | - | $243.33M(-31.7%) |
| Dec 2022 | $983.44M(+20.8%) | $356.17M(+63.8%) |
| Sep 2022 | - | $217.39M(+1.3%) |
| Jun 2022 | - | $214.56M(+9.9%) |
| Mar 2022 | - | $195.25M(-10.5%) |
| Dec 2021 | $814.35M(-6.1%) | $218.18M(+1.5%) |
| Sep 2021 | - | $214.87M(+16.5%) |
| Jun 2021 | - | $184.41M(-6.3%) |
| Mar 2021 | - | $196.90M(-31.5%) |
| Dec 2020 | $867.28M(+15.3%) | $287.48M(+48.6%) |
| Sep 2020 | - | $193.48M(-0.4%) |
| Jun 2020 | - | $194.28M(+1.2%) |
| Mar 2020 | - | $191.95M(-17.3%) |
| Dec 2019 | $752.33M(+14.1%) | $232.02M(+41.1%) |
| Sep 2019 | - | $164.40M(-9.3%) |
| Jun 2019 | - | $181.28M(+3.8%) |
| Mar 2019 | - | $174.64M(-2.7%) |
| Dec 2018 | $659.23M(+36.4%) | $179.51M(+9.5%) |
| Sep 2018 | - | $163.97M(-2.4%) |
| Jun 2018 | - | $168.03M(+13.7%) |
| Mar 2018 | - | $147.72M(-15.1%) |
| Dec 2017 | $483.13M(+23.0%) | $173.99M(+62.6%) |
| Sep 2017 | - | $107.00M(+1.1%) |
| Jun 2017 | - | $105.82M(+9.9%) |
| Mar 2017 | - | $96.31M(-19.2%) |
| Dec 2016 | $392.94M(+9.3%) | $119.19M(+25.7%) |
| Sep 2016 | - | $94.82M(+8.5%) |
| Jun 2016 | - | $87.40M(-4.5%) |
| Mar 2016 | - | $91.53M(-20.1%) |
| Dec 2015 | $359.46M(+37.3%) | $114.51M(+17.7%) |
| Sep 2015 | - | $97.26M(+28.3%) |
| Jun 2015 | - | $75.78M(+5.4%) |
| Mar 2015 | - | $71.91M(-3.8%) |
| Dec 2014 | $261.89M(+31.6%) | $74.78M(+14.1%) |
| Sep 2014 | - | $65.56M(+2.9%) |
| Jun 2014 | - | $63.73M(+10.2%) |
| Mar 2014 | - | $57.83M(-6.9%) |
| Dec 2013 | $198.95M(+16.4%) | $62.11M(+26.5%) |
| Sep 2013 | - | $49.09M(+6.7%) |
| Jun 2013 | - | $46.02M(+10.3%) |
| Mar 2013 | - | $41.73M(-9.3%) |
| Dec 2012 | $170.97M(+0.5%) | $45.99M(+16.0%) |
| Sep 2012 | - | $39.65M(-9.2%) |
| Jun 2012 | - | $43.64M(+4.7%) |
| Mar 2012 | - | $41.69M(-18.3%) |
| Dec 2011 | $170.19M(+8.5%) | $51.02M(+18.6%) |
| Sep 2011 | - | $43.03M(+10.7%) |
| Jun 2011 | - | $38.88M(+4.4%) |
| Mar 2011 | - | $37.26M(-11.9%) |
| Dec 2010 | $156.83M(+5.2%) | $42.28M(+12.5%) |
| Sep 2010 | - | $37.57M(-10.9%) |
| Jun 2010 | - | $42.17M(+21.2%) |
| Mar 2010 | - | $34.81M(-20.8%) |
| Dec 2009 | $149.14M(+24.0%) | $43.93M(+18.2%) |
| Sep 2009 | - | $37.17M(+3.8%) |
| Jun 2009 | - | $35.82M(+11.2%) |
| Mar 2009 | - | $32.22M(-14.6%) |
| Dec 2008 | $120.25M(+31.8%) | $37.73M(+28.8%) |
| Sep 2008 | - | $29.29M(+2.3%) |
| Jun 2008 | - | $28.62M(+16.3%) |
| Mar 2008 | - | $24.62M(+55.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $91.26M(+13.2%) | $15.87M(-44.5%) |
| Sep 2007 | - | $28.57M(+21.7%) |
| Jun 2007 | - | $23.47M(+0.5%) |
| Mar 2007 | - | $23.35M(+44.3%) |
| Dec 2006 | $80.61M(-10.8%) | $16.19M(-25.7%) |
| Sep 2006 | - | $21.80M(+0.5%) |
| Jun 2006 | - | $21.69M(+3.6%) |
| Mar 2006 | - | $20.94M(-11.6%) |
| Dec 2005 | $90.36M(-29.4%) | $23.67M(+18.7%) |
| Sep 2005 | - | $19.95M(-12.7%) |
| Jun 2005 | - | $22.86M(-4.2%) |
| Mar 2005 | - | $23.86M(-22.4%) |
| Dec 2004 | $128.05M(+0.7%) | $30.76M(-2.3%) |
| Sep 2004 | - | $31.47M(+0.9%) |
| Jun 2004 | - | $31.18M(-10.0%) |
| Mar 2004 | - | $34.64M(+11.1%) |
| Dec 2003 | $127.17M(-1.9%) | $31.18M(+2.7%) |
| Sep 2003 | - | $30.36M(-7.2%) |
| Jun 2003 | - | $32.73M(-0.5%) |
| Mar 2003 | - | $32.89M(+3.7%) |
| Dec 2002 | $129.62M(+30.4%) | $31.73M(-16.1%) |
| Sep 2002 | - | $37.81M(+16.7%) |
| Jun 2002 | - | $32.40M(+17.1%) |
| Mar 2002 | - | $27.68M(-6.0%) |
| Dec 2001 | $99.38M(+38.4%) | $29.44M(+22.6%) |
| Sep 2001 | - | $24.01M(-0.2%) |
| Jun 2001 | - | $24.06M(+10.0%) |
| Mar 2001 | - | $21.87M(-6.9%) |
| Dec 2000 | $71.78M(-12.7%) | $23.48M(+29.9%) |
| Sep 2000 | - | $18.07M(+19.2%) |
| Jun 2000 | - | $15.16M(+0.6%) |
| Mar 2000 | - | $15.06M(-44.6%) |
| Dec 1999 | $82.20M(+8.2%) | $27.20M(+45.5%) |
| Sep 1999 | - | $18.70M(-2.6%) |
| Jun 1999 | - | $19.20M(+12.3%) |
| Mar 1999 | - | $17.10M(-21.2%) |
| Dec 1998 | $76.00M(+13.1%) | $21.70M(+15.4%) |
| Sep 1998 | - | $18.80M(0.0%) |
| Jun 1998 | - | $18.80M(+11.9%) |
| Mar 1998 | - | $16.80M(-27.3%) |
| Dec 1997 | $67.20M(+23.5%) | $23.10M(+52.0%) |
| Sep 1997 | - | $15.20M(-1.9%) |
| Jun 1997 | - | $15.50M(+14.8%) |
| Mar 1997 | - | $13.50M(-27.4%) |
| Dec 1996 | $54.40M(+31.4%) | $18.60M(+57.6%) |
| Sep 1996 | - | $11.80M(-7.8%) |
| Jun 1996 | - | $12.80M(+14.3%) |
| Mar 1996 | - | $11.20M(-9.7%) |
| Dec 1995 | $41.40M(+13.7%) | $12.40M(+11.7%) |
| Sep 1995 | - | $11.10M(+19.4%) |
| Jun 1995 | - | $9.30M(+6.9%) |
| Mar 1995 | - | $8.70M(-33.1%) |
| Dec 1994 | $36.40M(+355.0%) | $13.00M(+58.5%) |
| Sep 1994 | - | $8.20M(+3.8%) |
| Jun 1994 | - | $7.90M(+11.3%) |
| Mar 1994 | - | $7.10M(-147.0%) |
| Dec 1993 | $8.00M(-75.2%) | -$15.10M(-296.1%) |
| Sep 1993 | - | $7.70M(-1.3%) |
| Jun 1993 | - | $7.80M(0.0%) |
| Mar 1993 | - | $7.80M(-70.2%) |
| Dec 1992 | $32.30M(+509.4%) | $26.20M(+1278.9%) |
| Sep 1992 | - | $1.90M(0.0%) |
| Jun 1992 | - | $1.90M(-5.0%) |
| Mar 1992 | - | $2.00M(+17.6%) |
| Dec 1991 | $5.30M(+152.4%) | $1.70M(+41.7%) |
| Sep 1991 | - | $1.20M(-70.0%) |
| Jun 1991 | - | $4.00M(+344.4%) |
| Mar 1991 | - | $900.00K |
| Dec 1990 | $2.10M | - |
FAQ
- What is Ionis Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual operating expenses year-on-year change?
- What is Ionis Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly operating expenses year-on-year change?
What is Ionis Pharmaceuticals annual total operating expenses?
The current annual operating expenses of IONS is $1.17B
What is the all time high annual operating expenses for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual total operating expenses is $1.17B
What is Ionis Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, IONS annual total operating expenses has changed by +$36.80M (+3.25%)
What is Ionis Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of IONS is $277.06M
What is the all time high quarterly operating expenses for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly total operating expenses is $356.17M
What is Ionis Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, IONS quarterly total operating expenses has changed by +$10.24M (+3.84%)